Atlas Trials

Di Wu

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Di Wu

RecordFirmDate
Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma (NCT04979585)Di Wu2021-07-15
Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma (NCT04331093)Di Wu2021-03-01
Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma (NCT03946943)Di Wu2019-07-19

Track Di Wu automatically

Every clearance here is in the API, with alerts when new ones post.